GSK
-
USA
GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion
GlaxoSmithKline headquarters in London on January 17, 2022. Hannah Mckay | Reuters UK pharmaceutical group GSK Signed an agreement to…
Read More » -
UK
GSK to buy US cancer treatment firm Nuvalent for $10.6bn | GSK
GSK’s new boss Luke Miels has signed one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) purchase of…
Read More » -
UK
GSK reports promising early results in ovarian and womb cancer drug trial | GSK
GSK has announced positive results for gynecological cancer treatment as its chief executive Luke Miels aims to accelerate drug development…
Read More » -
UK
GSK to buy food allergy drug maker RAPT in $2.2bn deal | GSK
GSK, the UK’s second-largest drugmaker, has announced a $2.2bn (£1.6bn) deal to buy a California biotech company developing a drug…
Read More » -
UK
UK must reform drug pricing to become life sciences superpower, says GSK boss | GSK
GSK’s outgoing chief executive, Emma Walmsley, has said the UK will struggle to become a “life sciences superpower” unless it…
Read More » -
UK
GSK’s Emma Walmsley to step down as chief executive after eight years | GSK
Britain’s second largest drug producer GSK announced that Emma Walmsley, chief manager eight years later, left a surprise. Walmsley, which…
Read More » -
USA
UK’s GSK announces $30 billion U.S. pharma investment amid Trump state visit
Rafael Henrique | LightoKet | Getty Images Britain GSK On Wednesday, President Donald Trump was the last pharmaceutical company to…
Read More »